|
|
| |
RISK MANAGEMENT |
| Intraoperative Management |
| |
|
| MATERNAL CO2 MONITORING |
- End-tidal or transcutaneous CO2 monitoring can be very useful for monitoring for intraoperative maternal complications in pregnant patients (see table at right).
-
Intrapertioneal CO2 insufflation may increase maternal PaCO2. Although probably not severe, alterations in maternal PaCO2 levels can lead to uterine artery contraction.
|
| INTRAOPERATIVE MEDICATIONS |
-
TOCOLYTICS
- Beta-agonist tocolytics are associated with maternal pulmonary edema, atrial fibrillation, chest pain, and ECG changes. [11]
- Magnesium may decrease platelet aggregation.
-
Ephedrine, if needed, is less likely to cause uterine artery spasm than other vasopressors.
|
|
 |
 |
|
|
| |
| Tocolytics have significant side effects - do not treat uterine contractions unless truly concerning of preterm labor. |
|
|